Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Compound Profile Scientific & Efficacy Data C 194 H 312 N 54 O 59 S 2 Molecular Formula 4409 g/mol Molecular Weight 159-195 hours (~7-8 days) Half-Life ~100% (subcutaneous) Bioavailability 1415456-99-3 CAS # 171397054 PubChem ID Developed By 2021 Thomas Kruse Novo Nordisk Primary Benefits Exceptional appetite suppression through dual amylin and calcitonin receptor activation, creating powerful and sustained satiety signals Impressive 10-15% weight loss alone, or 20%+ when combined with semaglutide in the CagriSema combination Uniquely designed to complement GLP-1 medications through an independent mechanism, dramatically enhancing results when combined Amino Acid Sequence Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (acylated with C18 diacid via gamma-Glu linker) Dosing How much do I take
For example, scientists can use 10mL of bacteriostatic water and aim for a concentration of 1mg/mL, thus making calculations considerably easier
When to Contact Your Healthcare Team Reach out to your medical provider or Patient Care Coordinator if you: Notice unusual changes in your medication's appearance Experience persistent pain or swelling at injection sites Have difficulty with dose calculations Need hands-on training or additional support Your Partner in Health At Affinity Whole Health, we understand that starting any injected medication is a significant step
Gorman, G
L.QiaoJ.et al
US$ 23.98
US$ 20.31
US$ 28.38
